Amrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amrx Today - Breaking & Trending Today

Amneal Pharmaceuticals (AMRX) Scheduled to Post Quarterly Earnings on Friday

Amneal Pharmaceuticals (NASDAQ:AMRX – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, May 3rd. Analysts expect the company to announce earnings of $0.08 per share for the quarter. Amneal Pharmaceuticals has set its FY 2024 guidance at 0.530-0.630 EPS.Parties that are interested in participating in […] ....

Piper Sandler , Amneal Pharmaceuticals , Amneal Pharmaceuticals Inc , Earnings History For Amneal Pharmaceuticals , News Ratings For Amneal Pharmaceuticals Daily , Goldman Sachs Group , Amneal Pharmaceuticals Trading , Get Free Report , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

Brokerages Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) PT at $7.31

Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have been given an average recommendation of “Buy” by the four research firms that are currently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have covered the […] ....

United States , Piper Sandler , Amneal Pharmaceuticals Inc , Goldman Sachs Group , Institutional Investors Weigh In On Amneal Pharmaceuticals , Amneal Pharmaceuticals , Connor Clark Lunn Investment Management Ltd , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals Stock Performance , Caxton Associates , Get Free Report , Marketbeat Ratings , Investment Management , Lunn Investment Management , Public Employees Retirement System , Get Free , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Up 1.9%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) shot up 1.9% on Wednesday . The company traded as high as $5.86 and last traded at $5.84. 420,424 shares were traded during trading, a decline of 72% from the average session volume of 1,499,807 shares. The stock had previously closed at $5.73. Analyst Ratings Changes A […] ....

Piper Sandler , Voloridge Investment Management , News Ratings For Amneal Pharmaceuticals Daily , Barclays Plc , Group Plc , Institutional Investors Weigh In On Amneal Pharmaceuticals , Goldman Sachs Group , Amneal Pharmaceuticals , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Company Profile , Pricet Rowe Associates Inc , Amneal Pharmaceuticals Price Performance , Vanguard Group Inc , Get Free Report , General Group Plc , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

Amneal Pharmaceuticals (NASDAQ:AMRX) Sees Strong Trading Volume

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) shares saw unusually-high trading volume on Wednesday . Approximately 454,208 shares changed hands during mid-day trading, a decline of 69% from the previous session’s volume of 1,481,910 shares.The stock last traded at $5.96 and had previously closed at $5.81. Analysts Set New Price Targets Several research firms […] ....

Piper Sandler , Vanguard Group Inc , Blackrock Inc , Millennium Management , Amneal Pharmaceuticals Company Profile , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals Stock , Amneal Pharmaceuticals Inc , Morgan Stanley , Goldman Sachs Group , Amneal Pharmaceuticals , Get Free Report , Capital Management , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,